Pan Cancer T in a €4.25 Million seed extension round with InnovationQuarter, Van Herk Ventures, Thuja, Swanbridge Capital and Erasmus MC, O&O Holdings

Biotech Health services Pharma

Investments

30 June 2024

Pan Cancer (company)

Biotech Health services Pharma

Total investments received (USD): 17.84m

Round value (USD): 4.58m

Round investors: InnovationQuarter Thuja Capital Management B.V. Swanbridge Capital Van Herk Ventures Erasmus MC O&O Holdings

Industry: Biotech Health services Pharma

Biotech Health services Manufacturing Pharma

Investments 04 November 2024

AI (big data) Biotech Health services Software Services

Investments 02 March 2024